Sibun Parida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sibun Parida has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Zhumur Ghosh
Division of Bioinformatics, Bose Institute, Kolkata, India
2 shared publications- Anchal Garg
University of Bolton, Bolton, UK
1 shared publication Arijita Sarkar
Bioinformatics Centre, Bose Institute, Kolkata 700054, India
1 shared publication- Bibekanand Mallick
RNAi and Functional Genomics Lab, Department of Life Science, National Institute of Technology Rourkela, Rourkela, India
1 shared publication Deepanjali Sharma
Central University of Rajasthan, Ajmer, Rajasthan, INDIA
1 shared publication- Jyoti Roy
RNAi and Functional Genomics Lab, Department of Life Science, National Institute of Technology, Rourkela, Odisha, India
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Distributed Sensor Networks
- Vol. 2026 (1) , 4232835
Physiological Reality Verification for Secure Healthcare Multimedia Internet of Things Using Crossmodal Semantic Integrity Learning
Modern healthcare multimedia Internet of Things (IoT) systems are systematically integrating face video, respiratory audio, and wearable physiological signals for remote clinical monitoring. However, this evidence can be replayed, spoofed, substituted, or temporally desynchronized before reaching clinical inference. To address these risks, we propose a physiological real‐time verification framework that facilitates an edge‐level admissibility firewall for secure healthcare multimedia IoT. Our proposed model first verifies whether multimodal evidence is biologically consistent across video‐derived rPPG, ECG–PPG timing, respiratory rhythm, SpO 2 trends, and respiratory‐audio events. A controlled multimodal integrity benchmark is constructed by integrating video‐physiology evidence from UBFC‐rPPG and PURE, wearable and ICU waveform evidence from BIDMC and MIMIC‐IV Waveform, and respiratory‐audio evidence from the ICBHI 2017 Respiratory Sound Database. We have generated clean samples using physiological compatibility matching, and attacked samples are created using video replay, respiratory‐audio replay, wearable spoofing, crossmodal desynchronization, physiological substitution, and respiratory‐event contradiction. Experimental evaluation shows that the proposed model achieves an attacked F 1‐score of 0.914 ± 0.013, AUROC of 0.956 ± 0.009, attack detection rate of 93.4 % ± 1.2 % , and false clinical acceptance rate of 5.6 % ± 0.9 % . Our model reduces physiological integrity error to 0.084 ± 0.007. Edge analysis shows that the 20 s evidence window provides the best trade‐off and requires 89.6 ± 6.9 ms inference latency and 1.24 ± 0.12 J per verification cycle. These results highlight the ability of the proposed framework to provide robust physiological evidence authentication before clinical decision‐making.
- 1 January 2026
- Published by Wiley in International Journal of Distributed Sensor Networks
- Vol. 2026 (1) , 4232835
Open AccessPhysiological Reality Verification for Secure Healthcare Multimedia Internet of Things Using Crossmodal Semantic Integrity Learning
Modern healthcare multimedia Internet of Things (IoT) systems are systematically integrating face video, respiratory audio, and wearable physiological signals for remote clinical monitoring. However, this evidence can be replayed, spoofed, substituted, or temporally desynchronized before reaching clinical inference. To address these risks, we propose a physiological real‐time verification framework that facilitates an edge‐level admissibility firewall for secure healthcare multimedia IoT. Our proposed model first verifies whether multimodal evidence is biologically consistent across video‐derived rPPG, ECG–PPG timing, respiratory rhythm, SpO 2 trends, and respiratory‐audio events. A controlled multimodal integrity benchmark is constructed by integrating video‐physiology evidence from UBFC‐rPPG and PURE, wearable and ICU waveform evidence from BIDMC and MIMIC‐IV Waveform, and respiratory‐audio evidence from the ICBHI 2017 Respiratory Sound Database. We have generated clean samples using physiological compatibility matching, and attacked samples are created using video replay, respiratory‐audio replay, wearable spoofing, crossmodal desynchronization, physiological substitution, and respiratory‐event contradiction. Experimental evaluation shows that the proposed model achieves an attacked F 1‐score of 0.914 ± 0.013, AUROC of 0.956 ± 0.009, attack detection rate of 93.4 % ± 1.2 % , and false clinical acceptance rate of 5.6 % ± 0.9 % . Our model reduces physiological integrity error to 0.084 ± 0.007. Edge analysis shows that the 20 s evidence window provides the best trade‐off and requires 89.6 ± 6.9 ms inference latency and 1.24 ± 0.12 J per verification cycle. These results highlight the ability of the proposed framework to provide robust physiological evidence authentication before clinical decision‐making.
- 1 February 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
AccessE-Algorithm to detect the accessible segments during LncRNA-mRNA interactions
Long noncoding RNAs (lncRNAs) constitutes a class of noncoding RNAs which are versatile molecules and perform various regulatory functions. A significant number of lncRNAs have been found in different organisms including Homo sapiens, but their functions are yet to be explored fully. LncRNAs target protein coding genes or mRNAs to regulate different functions. Hence it is highly challenging to find out its key target molecule and understand the function of these molecules. Predicting accessible energy between an lncRNA and an mRNA is an essential step to identify lncRNA targets further. The existing algorithms used for accessible energy calculation has several limitations and are unable to predict comprehensive interaction between lncRNAs and mRNAs. We have developed AccessE which identifies accessible segments of lncRNA and mRNA and provides the accessible energy of the two molecules. AccessE has been used to calculate the accessible energy for a set of experimentally validated lncRNA-target mRNA pairs. Proper evaluation of accessible energy between multiple accessible segments of lncRNA and mRNA, provides in-depth understanding of lncRNA-mRNA interaction.
- 1 February 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
AccessE-Algorithm to detect the accessible segments during LncRNA-mRNA interactions
Long noncoding RNAs (lncRNAs) constitutes a class of noncoding RNAs which are versatile molecules and perform various regulatory functions. A significant number of lncRNAs have been found in different organisms including Homo sapiens, but their functions are yet to be explored fully. LncRNAs target protein coding genes or mRNAs to regulate different functions. Hence it is highly challenging to find out its key target molecule and understand the function of these molecules. Predicting accessible energy between an lncRNA and an mRNA is an essential step to identify lncRNA targets further. The existing algorithms used for accessible energy calculation has several limitations and are unable to predict comprehensive interaction between lncRNAs and mRNAs. We have developed AccessE which identifies accessible segments of lncRNA and mRNA and provides the accessible energy of the two molecules. AccessE has been used to calculate the accessible energy for a set of experimentally validated lncRNA-target mRNA pairs. Proper evaluation of accessible energy between multiple accessible segments of lncRNA and mRNA, provides in-depth understanding of lncRNA-mRNA interaction.
- 16 January 2017
- Published by Oxford University Press (OUP) in Molecular BioSystems
- Vol. 13 (3) , 565-576
Small RNA sequencing revealed dysregulated piRNAs in Alzheimer's disease and their probable role in pathogenesis
PIWI-interacting RNAs (piRNAs), ∼23–36 nucleotide-long small non-coding RNAs, earlier believed to be germline-specific, have now been identified in somatic cells including neural cells. However, piRNAs have not yet been studied in the human brain (HB) and Alzheimer's disease (AD)-affected brain. In this study, by next-generation small RNA sequencing, 564 and 451 piRNAs were identified in the HB and AD-affected brain respectively. The majority of the neuronal piRNAs have intronic origin wherein primary piRNAs are mostly from the negative strand. piRNAs originating from the coding sequence of mRNAs and tRNAs are highly conserved compared to other genomic contexts. We found 1923 mRNAs significantly down-regulated in AD as the predicted targets of 125 up-regulated piRNAs. The filtering of targets based on our criteria coupled with pathway enrichment analysis of all the predicted targets resulted in five most significant AD-associated pathways enriched with four genes (CYCS, LIN7C, KPNA6, and RAB11A) found to be regulated by four piRNAs. The qRT–PCR study verified the reciprocal expression of piRNAs and their targets. This study provides the first evidence of piRNAs in the HB and AD which will provide the foundation for future studies to unravel the regulatory role of piRNAs in the human brain and associated diseases. The sequencing data have been submitted to the GEO database (Accession no. GSE85075).
- 16 January 2017
- Published by Oxford University Press (OUP) in Molecular BioSystems
- Vol. 13 (3) , 565-576
Small RNA sequencing revealed dysregulated piRNAs in Alzheimer's disease and their probable role in pathogenesis
PIWI-interacting RNAs (piRNAs), ∼23–36 nucleotide-long small non-coding RNAs, earlier believed to be germline-specific, have now been identified in somatic cells including neural cells. However, piRNAs have not yet been studied in the human brain (HB) and Alzheimer's disease (AD)-affected brain. In this study, by next-generation small RNA sequencing, 564 and 451 piRNAs were identified in the HB and AD-affected brain respectively. The majority of the neuronal piRNAs have intronic origin wherein primary piRNAs are mostly from the negative strand. piRNAs originating from the coding sequence of mRNAs and tRNAs are highly conserved compared to other genomic contexts. We found 1923 mRNAs significantly down-regulated in AD as the predicted targets of 125 up-regulated piRNAs. The filtering of targets based on our criteria coupled with pathway enrichment analysis of all the predicted targets resulted in five most significant AD-associated pathways enriched with four genes (CYCS, LIN7C, KPNA6, and RAB11A) found to be regulated by four piRNAs. The qRT–PCR study verified the reciprocal expression of piRNAs and their targets. This study provides the first evidence of piRNAs in the HB and AD which will provide the foundation for future studies to unravel the regulatory role of piRNAs in the human brain and associated diseases. The sequencing data have been submitted to the GEO database (Accession no. GSE85075).